Bionomics Return On Equity from 2010 to 2024

BNOX Stock  USD 0.28  0.02  6.67%   
Bionomics Return On Equity yearly trend continues to be fairly stable with very little volatility. Return On Equity is likely to outpace its year average in 2024. Return On Equity is a measure of the profitability of Bionomics Ltd ADR in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(885.75)
Current Value
(841.47)
Quarterly Volatility
303.78023599
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 412.7 K, Interest Expense of 19 K or Other Operating Expenses of 18.8 B, as well as many indicators such as Price To Sales Ratio of 152.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.37. Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.
  
Check out the analysis of Bionomics Correlation against competitors.

Latest Bionomics' Return On Equity Growth Pattern

Below is the plot of the Return On Equity of Bionomics Ltd ADR over the last few years. Return on Equity is the amount of Bionomics ADR net income returned as a percentage of Bionomics equity. Return on equity measures Bionomics profitability by revealing how much profit Bionomics Ltd ADR generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Bionomics' Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionomics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported -0.7810 Years Trend
Slightly volatile
   Return On Equity   
       Timeline  

Bionomics Return On Equity Regression Statistics

Arithmetic Mean(115.67)
Coefficient Of Variation(262.63)
Mean Deviation199.45
Median(0.38)
Standard Deviation303.78
Sample Variance92,282
Range886
R-Value(0.59)
Mean Square Error64,876
R-Squared0.35
Significance0.02
Slope(40.03)
Total Sum of Squares1.3M

Bionomics Return On Equity History

2024 -841.47
2023 -885.75
2022 -1.44
2021 -0.55
2020 -0.24
2019 -0.81
2018 -0.83

About Bionomics Financial Statements

Bionomics investors use historical fundamental indicators, such as Bionomics' Return On Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bionomics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Equity(885.75)(841.47)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.